Korean J Androl.
2008 Dec;26(4):237-239.
Polycythemia as a Complication of Long-acting Injectable Testosterone Undecanoate
- Affiliations
-
- 1Department of Urology, Korea University College of Medicine, Seoul, Korea. dgmoon@korea.ac.kr
Abstract
- Polycythemia is a condition in which the red blood cell count is increased due to an inherited or acquired mutation, a physiologic response to hypoxia, autonomous erythropoietin production, or deliberate erythropoietin administration. Higher testosterone levels appear to act as a stimulus for erythropoiesis and testosterone replacement therapies have rarely been reported as causes of polycythemia. We report here a case of a 51-year-old man with polycythemia that was caused by long-acting testosterone undecanoate (Nebido(R)).
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Efficacy and Safety of Long-acting Injectable Testosterone Undecanoate for Treating Patients with Testosterone Deficiency Syndrome
- Oral Testosterone Undecanoate(Andriol(R)) for Increasing Serum Testosterone Level in Late Onset Hypogonadism Patients
- Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
- Testosterone replacement therapy and monitoring for the male patients with testosterone deficiency syndrome
- Recent Update on Late-onset Hypogonadism in Males
